These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35088106)

  • 1. Cardiotoxicity of cyclophosphamide's metabolites: an in vitro metabolomics approach in AC16 human cardiomyocytes.
    Dionísio F; Araújo AM; Duarte-Araújo M; Bastos ML; Guedes de Pinho P; Carvalho F; Costa VM
    Arch Toxicol; 2022 Feb; 96(2):653-671. PubMed ID: 35088106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of metabolites of cyclophosphamide in cardiotoxicity.
    Kurauchi K; Nishikawa T; Miyahara E; Okamoto Y; Kawano Y
    BMC Res Notes; 2017 Aug; 10(1):406. PubMed ID: 28807058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
    Reis-Mendes A; Gomes AS; Carvalho RA; Carvalho F; Remião F; Pinto M; Bastos ML; Sousa E; Costa VM
    Arch Toxicol; 2017 Apr; 91(4):1871-1890. PubMed ID: 27629428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative In Vitro Study of the Cytotoxic Effects of Doxorubicin's Main Metabolites on Cardiac AC16 Cells Versus the Parent Drug.
    Reis-Mendes A; Vitorino-Oliveira C; Ferreira M; Carvalho F; Remião F; Sousa E; de Lourdes Bastos M; Costa VM
    Cardiovasc Toxicol; 2024 Mar; 24(3):266-279. PubMed ID: 38347287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system.
    Oleaga C; Riu A; Rothemund S; Lavado A; McAleer CW; Long CJ; Persaud K; Narasimhan NS; Tran M; Roles J; Carmona-Moran CA; Sasserath T; Elbrecht DH; Kumanchik L; Bridges LR; Martin C; Schnepper MT; Ekman G; Jackson M; Wang YI; Note R; Langer J; Teissier S; Hickman JJ
    Biomaterials; 2018 Nov; 182():176-190. PubMed ID: 30130706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation.
    DeLeve LD
    Hepatology; 1996 Oct; 24(4):830-7. PubMed ID: 8855185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells.
    Reis-Mendes A; Carvalho F; Remião F; Sousa E; Bastos ML; Costa VM
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30862114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention.
    Nishikawa T; Miyahara E; Kurauchi K; Watanabe E; Ikawa K; Asaba K; Tanabe T; Okamoto Y; Kawano Y
    PLoS One; 2015; 10(6):e0131394. PubMed ID: 26114497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase P protects against cyclophosphamide-induced cardiotoxicity in mice.
    Conklin DJ; Haberzettl P; Jagatheesan G; Baba S; Merchant ML; Prough RA; Williams JD; Prabhu SD; Bhatnagar A
    Toxicol Appl Pharmacol; 2015 Jun; 285(2):136-48. PubMed ID: 25868843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sulfhydryl compounds and glutathione depletion on rat heart myocyte toxicity induced by 4-hydroperoxycyclophosphamide and acrolein in vitro.
    Dorr RT; Lagel K
    Chem Biol Interact; 1994 Nov; 93(2):117-28. PubMed ID: 8082231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity.
    Reis-Mendes AF; Sousa E; de Lourdes Bastos M; Costa VM
    Curr Drug Metab; 2015; 17(1):75-90. PubMed ID: 26526839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinochrome D Attenuates Doxorubicin-Induced Cardiomyocyte Death via Improving Glutathione Metabolism and Attenuating Oxidative Stress.
    Yoon CS; Kim HK; Mishchenko NP; Vasileva EA; Fedoreyev SA; Stonik VA; Han J
    Mar Drugs; 2018 Dec; 17(1):. PubMed ID: 30577438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential.
    Palmer JA; Smith AM; Gryshkova V; Donley ELR; Valentin JP; Burrier RE
    Toxicol Sci; 2020 Apr; 174(2):218-240. PubMed ID: 32040181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde dehydrogenase 2 activation ameliorates cyclophosphamide-induced acute cardiotoxicity via detoxification of toxic aldehydes and suppression of cardiac cell death.
    Liu W; Zhai X; Wang W; Zheng B; Zhang Z; Fan X; Chen Y; Wang J
    J Mol Cell Cardiol; 2018 Aug; 121():134-144. PubMed ID: 29981795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and histological evaluations of cyclophosphamide-induced acute cardiotoxicity in wistar rats: The role of turmeric extract (curcuma).
    Komolafe OA; Arayombo BE; Abiodun AA; Saka OS; Abijo AZ; Ojo SK; Fakunle OO
    Morphologie; 2020 May; 104(345):133-142. PubMed ID: 31928923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insights into the mechanism of cyclophosphamide-induced bladder toxicity: chloroacetaldehyde's contribution to urothelial dysfunction in vitro.
    Mills KA; Chess-Williams R; McDermott C
    Arch Toxicol; 2019 Nov; 93(11):3291-3303. PubMed ID: 31598736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes.
    Kopljar I; De Bondt A; Vinken P; Teisman A; Damiano B; Goeminne N; Van den Wyngaert I; Gallacher DJ; Lu HR
    Br J Pharmacol; 2017 Nov; 174(21):3766-3779. PubMed ID: 28094846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of cyclophosphamide.
    de Jonge ME; Huitema AD; Rodenhuis S; Beijnen JH
    Clin Pharmacokinet; 2005; 44(11):1135-64. PubMed ID: 16231966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells.
    Pereira-Oliveira M; Reis-Mendes A; Carvalho F; Remião F; Bastos ML; Costa VM
    Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30634681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.